Ajanta Pharma’s Generic Anti-Asthma Chewable Tablets Approved By US FDA – International Business Times


International Business Times

Ajanta Pharma's Generic Anti-Asthma Chewable Tablets Approved By US FDA
International Business Times
According to U.S. National Library of Medicine, Montelukast is used to prevent chest tightness, difficulty in breathing and wheezing and coughing caused by asthma. In addition, it is used to prevent the symptoms associated with seasonal allergies and
Ajanta Pharma launches generic asthma treatment tablets in USEconomic Times
Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.com
Ajanta Pharma launches anti-asthma tablets in USMyiris.com

all 17 news articles »

View full post on asthma – Google News

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

Condition:   Respiratory Disorders
Interventions:   Drug: Reference Montelukast;   Drug: Test 1 Montelukast;   Drug: Test 2 Montelukast
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified December 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days